|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 118.85 EUR | +1.71% |
|
-0.46% | -15.05% |
| 03:59pm | Merck KGaA's SpringWorks Gets UK Clearance for Plexiform Neurofibromas Therapy | MT |
| 02:37pm | UK's MHRA approves mirdametinib to treat plexiform neurofibromas | RE |
Analyst Reco.
Search
12-08 | ZD | |
12-03 | DP | |
12-02 | DP | |
11-17 | ZD | |
11-14 | ZD | |
11-14 | ZD | |
11-13 | ZD | |
11-13 | ![]() | |
11-13 | ZD | |
11-13 | ZD | |
11-13 | DP | |
11-13 | DP | |
11-10 | DP | |
11-03 | ZD | |
10-31 | DP | |
10-30 | ZD | |
10-29 | ZD | |
10-29 | ZD | |
10-29 | ZD | |
10-23 | ZD | |
10-22 | ZD | |
10-20 | ZD | |
10-20 | ||
10-17 | RE | |
10-17 | ZD |
No results for this search
Filters
- Stock Market
- Equities
- MRK Stock
- News Merck KGaA
- Analyst Reco.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition



















